0.0882 CHF
7.06 M CHF
410.04 K CHF
89.68 M
About Addex Therapeutics Ltd
Sector
Industry
CEO
Timothy Dyer
Website
Headquarters
Geneva
Founded
2002
ISIN
CH0029850754
FIGI
BBG000LHBCW4
Addex Therapeutics Ltd. is a biopharmaceutical company, which engages in the development of drugs for human health. It develops novel, orally available, and small molecule allosteric modulators for neurological disorders. Its pipeline includes Dipraglurant, ADX71149, GABAB PAM, mGlu7 NAM, mGlu2 NAM, mGlu4 PAM, and mGlu3 PAM. The company was founded by Vincent Mutel, Timothy Dyer, and Mark Epping-Jordan in 2002 and is headquartered in Geneva, Switzerland.
Related stocks
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of ADXN is 0.0678 CHF — it hasn't changed in the past 24 hours. Watch Addex Therapeutics Ltd stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SIX exchange Addex Therapeutics Ltd stocks are traded under the ticker ADXN.
ADXN stock has risen by 9.06% compared to the previous week, the month change is a 8.65% rise, over the last year Addex Therapeutics Ltd has showed a −0.29% decrease.
ADXN reached its all-time high on May 22, 2007 with the price of 75.0000 CHF, and its all-time low was 0.0362 CHF and was reached on Nov 29, 2023. View more price dynamics on ADXN chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
ADXN stock is 43.87% volatile and has beta coefficient of 0.44. Track Addex Therapeutics Ltd stock price on the chart and check out the list of the most volatile stocks — is Addex Therapeutics Ltd there?
Today Addex Therapeutics Ltd has the market capitalization of 5.68 M, it has increased by 3.57% over the last week.
Yes, you can track Addex Therapeutics Ltd financials in yearly and quarterly reports right on TradingView.
ADXN net income for the last quarter is −1.47 M CHF, while the quarter before that showed −1.21 M CHF of net income which accounts for −22.15% change. Track more Addex Therapeutics Ltd financial stats to get the full picture.
No, ADXN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Sep 13, 2025, the company has 2 employees. See our rating of the largest employees — is Addex Therapeutics Ltd on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Addex Therapeutics Ltd EBITDA is −2.38 M CHF, and current EBITDA margin is −608.50%. See more stats in Addex Therapeutics Ltd financial statements.
Like other stocks, ADXN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Addex Therapeutics Ltd stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Addex Therapeutics Ltd technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Addex Therapeutics Ltd stock shows the neutral signal. See more of Addex Therapeutics Ltd technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.